Osteoarthritis drug developer Paradigm says its purchase of an oral drug candidate won’t distract it from its key phase III knee trial. In a heavily back-ended deal, Paradigm will pay as much as $16.5 ...
The book “Cyber Persistence Theory” by Michael Fischerkeller, Emily Goldman, and Richard Harknett suggests a paradigm shift of the strategic environment shaped by the Cold War and twenty years of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results